Login

Username:
Password:
Remember me
Register
Change Password
Forgotten Password?
The sociable bug
Bacteria are very sociable units of life which can physically and chemically interact with one another. Researchers at Binghamton University, State University of New York, Center for Biofilm Engineering at Montana State University and the South West Regional Wound Care Center in Lubbock, Texas have found that depending on the 'language' (cell-cell communication molecules) spoken by bacteria will determine whether they are 'good' or 'bad' for the host. Read more about this fascinating insight into bacteria at Bug chatter

Sat 09 Jan 2010 by Perry Lesion


NPWT under FDA scrutiny
Care facilities should lookout for serious complications incl. risk of death, fatal bleeding and infections from use of Negative Pressure Wound Therapy (NPWT) systems says U.S. Food and Drug Administration.

Apparently there have been reports of 6 deaths and 77 injuries associated with NPWT systems over the past two years with bleeding being the most serious. There have been 32 reports involving foam dressing retention in the wound and where the majority required surgery for its removal. Read on... Four-Wound-Care-Precautions

Sat 09 Jan 2010 by Perry Lesion



Sorbion.com


Photizo


Melladerm Plus

Interesting case study - Necrolytic Migratory Erythema
A 63-year-old woman presented with a 4 1/2-year history of diabetes mellitus and an ulcerating rash - read more in Images in Clinical Medicine at Glucagonoma

Sun 10 Jan 2010 by Perry Lesion


Smith & Nephew agrees to partner with Gunze, Japan.
Smith & Nephew have agreed to an exclusive distributorship of PELNAC dermal replacement in Japan, South Africa, Australia and New Zealand. PELNAC is a collagen matrix with silicone top layer for use on full thickness injuries such as burns and trauma. The full story may be found at PELNAC

Fri 25 Dec 2009 by Perry Lesion


Smith & Nephew completes Nucryst buyout
Smith & Nephew (Wound Management Division) completed its USD 21 million deal for Nucryst Pharmaceuticals Corp. The nanocrystalline silver technology used in the Acticoat wound dressing together with the related intelectual property and manufacturing assets will be absorbed into the S&N fold. Read more at Nucryst buyout

Thu 24 Dec 2009 by Perry Lesion